Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention Funding
12:14pm, Wednesday, 19'th Mar 2025
Gilead stock tumbled Wednesday on reports HHS could slash federal funding for HIV prevention, a staple in Gilead Sciences' topline. The post Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention
Buy 3 U.S. Giants Flying High Year to Date Defying Severe Volatility
11:10am, Wednesday, 19'th Mar 2025
Three U.S. bigwigs flying high year to date with more upside are GILD, GE and PGR.
Gilead Sciences Stock Slips on Possible HIV Funding Cut
10:37am, Wednesday, 19'th Mar 2025
Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is under review by the Trump administration, and the Health and Human Services D
Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding
09:22am, Wednesday, 19'th Mar 2025
Gilead Sciences is the maker of Biktarvy and Descovy, two drugs used to treat the virus.
GILD Stock Trading Close to Its 52-Week High: Should You Buy or Sell?
04:00pm, Monday, 17'th Mar 2025
Gilead Sciences hits a 52-week high buoyed by investor optimism. We believe there is still room for growth and recommend the stock to investors.
Calls of the Day: Shake Shack, Starbucks, 3M, Gilead Sciences, Eli Lilly
01:51pm, Friday, 14'th Mar 2025
The Investment Committee debate the latest Calls of the Day.
Follow the Leader: 2 Biopharma Stocks Showing Relative Strength in 2025
01:12pm, Thursday, 13'th Mar 2025
Despite a correction to begin the year, there are a few pockets of the market that are working.
GILD vs. VRTX: Which Stock Is the Better Value Option?
01:09pm, Thursday, 13'th Mar 2025
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Gilead Sciences (GILD) or Vertex Pharmaceuticals (VRTX). But which of these two stocks presen
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
10:02am, Thursday, 13'th Mar 2025
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
GILD Data on Once-Yearly Lenacapavir for HIV Prevention Positive
04:00pm, Wednesday, 12'th Mar 2025
Gilead Sciences' data on two novel, once-yearly formulations of lenacapavir for PrEP support the further development of the drug.
Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option
08:30am, Wednesday, 12'th Mar 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment port
Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference - (Transcript)
02:14pm, Tuesday, 11'th Mar 2025
Gilead Sciences, Inc. (NASDAQ:GILD ) Leerink Partners Global Healthcare Conference Call March 11, 2025 10:40 AM ET Company Participants Cindy Perettie - Executive Vice President and Global Head, Kite
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavi
The Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)
04:20am, Tuesday, 11'th Mar 2025
In 2024, technology stocks involved in artificial intelligence (AI) led the Nasdaq-100 index higher, while healthcare stocks struggled due in part to concerns about how Robert F. Kennedy's nomination
S&P 500 ETF's Worst Week Since September: 5 Top Stocks Poised to Rise
02:00pm, Monday, 10'th Mar 2025
These top-ranked stocks of the S&P 500 index have gained in the index's worst week since September. These stocks have more room to run.
